Back to Search Start Over

Whole-Exome Sequencing Analyses Support a Role of Vitamin D Metabolism in Ischemic Stroke.

Authors :
Xie Y
Acosta JN
Ye Y
Demarais ZS
Conlon CJ
Chen M
Zhao H
Falcone GJ
Source :
Stroke [Stroke] 2023 Mar; Vol. 54 (3), pp. 800-809. Date of Electronic Publication: 2023 Feb 10.
Publication Year :
2023

Abstract

Background: Ischemic stroke (IS) is a highly heritable trait, and genome-wide association studies have identified several commonly occurring susceptibility risk loci for this condition. However, there are limited data on the contribution of rare genetic variation to IS.<br />Methods: We conducted an exome-wide study using whole-exome sequencing data from 152 058 UK Biobank participants, including 1777 IS cases. We performed single-variant analyses for rare variants and gene-based analyses for loss-of-function and deleterious missense rare variants. We validated these results through (1) gene-based testing using summary statistics from MEGASTROKE-a genome-wide association study of IS that included 67 162 IS cases and 454 450 controls, (2) gene-based testing using individual-level data from 1706 IS survivors, including 142 recurrent IS cases, enrolled in the VISP trial (Vitamin Intervention for Stroke Prevention); and (3) gene-based testing against neuroimaging phenotypes related to cerebrovascular disease using summary-level data from 42 310 UK Biobank participants with available magnetic resonance imaging data.<br />Results: In single-variant association analyses, none of the evaluated variants were associated with IS at genome-wide significance levels ( P <5×10 <superscript>-8</superscript> ). In the gene-based analysis focused on loss-of-function and deleterious missense variants, rare genetic variation at CYP2R1 was significantly associated with IS risk ( P =2.6×10 <superscript>-6</superscript> ), exceeding the Bonferroni-corrected threshold for 16 074 tests ( P <3.1×10 <superscript>-6</superscript> ). Validations analyses indicated that CYP2R1 was associated with IS risk in MEGASTROKE (gene-based test, P =0.003), with IS recurrence in the VISP trial (gene-based test, P =0.001) and with neuroimaging traits (white matter hyperintensity, mean diffusivity, and fractional anisotropy) in the UK Biobank neuroimaging study (all gene-based tests, P <0.05).<br />Conclusions: Because CYP2R1 plays an important role in vitamin D metabolism and existing observational evidence suggests an association between vitamin D levels and cerebrovascular disease, our results support a role of this pathway in the occurrence of IS.

Details

Language :
English
ISSN :
1524-4628
Volume :
54
Issue :
3
Database :
MEDLINE
Journal :
Stroke
Publication Type :
Academic Journal
Accession number :
36762557
Full Text :
https://doi.org/10.1161/STROKEAHA.122.040883